BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11487003)

  • 21. Expression and analysis of a split premature termination codon in FGG responsible for congenital afibrinogenemia: escape from RNA surveillance mechanisms in transfected cells.
    Neerman-Arbez M; Germanos-Haddad M; Tzanidakis K; Vu D; Deutsch S; David A; Morris MA; de Moerloose P
    Blood; 2004 Dec; 104(12):3618-23. PubMed ID: 15284111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypofibrinogenaemia with compound heterozygosity for two gamma chain mutations - gamma 82 Ala-->Gly and an intron two GT-->AT splice site mutation.
    Wyatt J; Brennan SO; May S; George PM
    Thromb Haemost; 2000 Sep; 84(3):449-52. PubMed ID: 11019970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia.
    Neerman-Arbez M; de Moerloose P; Bridel C; Honsberger A; Schönbörner A; Rossier C; Peerlinck K; Claeyssens S; Di Michele D; d'Oiron R; Dreyfus M; Laubriat-Bianchin M; Dieval J; Antonarakis SE; Morris MA
    Blood; 2000 Jul; 96(1):149-52. PubMed ID: 10891444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel frameshift mutation in FGA (c.1846 del A) leading to congenital afibrinogenemia in a consanguineous Syrian family.
    Levrat E; Aboukhamis I; de Moerloose P; Farho J; Chamaa S; Reber G; Fort A; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):148-50. PubMed ID: 21245743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and functional characterization of a novel nonsense mutation in FGA accounting for congenital afibrinogenemia in six Egyptian patients.
    Abdel Wahab M; de Moerloose P; Fish RJ; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):164-7. PubMed ID: 20051841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation of the translation initiation codon in FGA causes congenital afibrinogenemia.
    Tirefort Y; Alson OR; de Moerloose P; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):556-8. PubMed ID: 22732251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nonsense mutation in FGA g.3807C-->T (p.R159X) causes afibrinogenaemia in the homozygous form.
    Marchi Cappelletti R; Tersek Y; Ruiz-Sáez A; Meyer M
    Acta Haematol; 2009; 121(4):216-7. PubMed ID: 19468208
    [No Abstract]   [Full Text] [Related]  

  • 28. Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion.
    Vu D; Bolton-Maggs PH; Parr JR; Morris MA; de Moerloose P; Neerman-Arbez M
    Blood; 2003 Dec; 102(13):4413-5. PubMed ID: 12893758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Afibrinogenemia resulting from homozygous nonsense mutation in A alpha chain gene associated with multiple thrombotic episodes.
    Simsek I; de Mazancourt P; Horellou MH; Erdem H; Pay S; Dinc A; Samama MM
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):247-53. PubMed ID: 18388508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of congenital afibrinogenemia: fibrinogen Hakata, a novel nonsense mutation of the fibrinogen gamma-chain gene.
    Iida H; Ishii E; Nakahara M; Urata M; Wakiyama M; Kurihara M; Watanabe K; Kai T; Ihara K; Kinoshita S; Hamasaki N
    Thromb Haemost; 2000 Jul; 84(1):49-53. PubMed ID: 10928469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families.
    Amri Y; Toumi Nel H; Hadj Fredj S; de Moerloose P
    Thromb Res; 2016 Jul; 143():11-6. PubMed ID: 27164460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4 + 1 G-->T.
    Attanasio C; de Moerloose P; Antonarakis SE; Morris MA; Neerman-Arbez M
    Blood; 2001 Mar; 97(6):1879-81. PubMed ID: 11238133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fibrinogen beta chain gene mutation contributes to one congenital afibrinogenemia].
    Xu XC; Zhou RF; Wu JS; Fang Y; Wang XF; Zhai ZM; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):137-9. PubMed ID: 15946523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetic analysis of a Chinese family with inherited afibrinogenemia].
    Fang Y; Wang XF; Wang HL; Fu QH; Wu WM; Ding QL; Dai J; Hu YQ; Wang ZY
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2054-7. PubMed ID: 14703415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion.
    Platè M; Asselta R; Spena S; Spreafico M; Fagoonee S; Peyvandi F; Tenchini ML; Duga S
    Blood Cells Mol Dis; 2008; 41(3):292-7. PubMed ID: 18676163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sites.
    Spena S; Duga S; Asselta R; Malcovati M; Peyvandi F; Tenchini ML
    Blood; 2002 Dec; 100(13):4478-84. PubMed ID: 12393540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel fibrinogen Aalpha chain mutation associated with afibrinogenaemia.
    Saravanan L; Brennan S; George P; Lowen R; Kirkland M; Campbell P
    Pathology; 2007 Oct; 39(5):519-20. PubMed ID: 17886104
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inherited afibrinogenemia caused by compound heterozygous mutations in the beta beta-chain of fibrinogen].
    Fang Y; Wang HL; Wang XF; Fu QH; Wang WB; Xie S; Zhou RF; Dai J; Wang ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1086-9. PubMed ID: 16403286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of afibrinogenemia associated with A-alpha chain gene compound heterozygosity (HUMFIBRA c.[4110delA]+[3200+1G>T]).
    Angles-Cano E; Mathonnet F; Dreyfus M; Claeyssens S; de Mazancourt P
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):73-5. PubMed ID: 17179831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia.
    Vu D; Di Sanza C; Caille D; de Moerloose P; Scheib H; Meda P; Neerman-Arbez M
    Hum Mol Genet; 2005 Nov; 14(21):3271-80. PubMed ID: 16195396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.